AU2003288857A1 - New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor - Google Patents

New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor

Info

Publication number: AU2003288857A1
Authority: AU; Australia
Prior art keywords: igf; inhibitors; receptor; phenyl; new substituted
Prior art date: 2002-12-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003288857A

Inventor

Magnus Axelson

Olle Larsson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Swedish Orphan Biovitrum AB

Original Assignee

Axelar AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-18

Filing date

2003-12-18

Publication date

2004-07-09

2003-12-18 Application filed by Axelar AB filed Critical Axelar AB

2004-07-09 Publication of AU2003288857A1 publication Critical patent/AU2003288857A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003288857A 2002-12-18 2003-12-18 New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor Abandoned AU2003288857A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0203746-3		2002-12-18
SE0203746A SE0203746D0 (en)	2002-12-18	2002-12-18	New compounds
PCT/SE2003/002010 WO2004054996A1 (en)	2002-12-18	2003-12-18	New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor

Publications (1)

Publication Number	Publication Date
AU2003288857A1 true AU2003288857A1 (en)	2004-07-09

Family

ID=20289899

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003288857A Abandoned AU2003288857A1 (en)	2002-12-18	2003-12-18	New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor

Country Status (3)

Country	Link
AU (1)	AU2003288857A1 (en)
SE (1)	SE0203746D0 (en)
WO (1)	WO2004054996A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7625859B1 (en)	2000-02-16	2009-12-01	Oregon Health & Science University	HER-2 binding antagonists
US8044067B2 (en) *	2005-09-09	2011-10-25	Analytecon S.A.	Isoquinolines as IGF-1R inhibitors
BRPI0616731A2 (en) *	2005-09-09	2016-08-23	Analytecon Sa	isoquinoline derivatives as igf-1r inhibitors
WO2009100349A1 (en)	2008-02-09	2009-08-13	The Trustees Of Columbia University In The City Of New York	Analogues of (-)-picropodophyllin, synthesis and uses thereof
WO2011083391A2 (en)	2010-01-05	2011-07-14	Pfizer Inc.	Biomarkers for anti-igf-ir cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU201672B (en) *	1984-12-28	1990-12-28	Conpharm Ab	Process for producing pharmaceutical compositions comprising podophyllotoxin
SE0102168D0 (en) *	2001-06-19	2001-06-19	Karolinska Innovations Ab	New use and new compounds

2002
- 2002-12-18 SE SE0203746A patent/SE0203746D0/en unknown
2003
- 2003-12-18 AU AU2003288857A patent/AU2003288857A1/en not_active Abandoned
- 2003-12-18 WO PCT/SE2003/002010 patent/WO2004054996A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004054996A1 (en)	2004-07-01
SE0203746D0 (en)	2002-12-18

Similar Documents

Publication	Publication Date	Title
AU2003280188A1 (en)	2004-06-30	Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
AU2003235676A1 (en)	2003-07-30	Tricyclic-bis-enone derivatives and methods of use thereof
AU2003303231A1 (en)	2004-07-14	Benzoxazines and derivatives thereof as inhibitors of pi3ks
AU2003303128A1 (en)	2004-08-13	Inhibitors and methods of use thereof
PL375877A1 (en)	2005-12-12	Hydantoine derivatives and their use as tace inhibitors
AU2003237987A1 (en)	2003-12-22	Novel sweetener compositions and methods of use
AU2003217870A1 (en)	2003-09-16	Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en)	2004-04-19	Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en)	2003-09-16	Pin1-modulating compounds and methods of use thereof
AU2003259735A1 (en)	2004-02-25	Small-mer compositions and methods of use
AU2003251559A1 (en)	2004-01-06	Heterocyclic inhibitors of kinases
AU2003213673A1 (en)	2003-09-16	Pin1-modulating compounds and methods of use thereof
AU2003302919A1 (en)	2004-06-30	Pyridine derivatives as jnk inhibitors and their use
AU2003217105A1 (en)	2003-09-16	Novel of cytokine inhibitors
AU2003269364A1 (en)	2004-05-25	Use of piperazine derivatives as ccr1 antagonists
AU2003299441A1 (en)	2004-07-14	Nf-hev compositions and methods of use
AU2003301216A1 (en)	2004-07-22	Novel use of liver x receptor agonists
AU2003240668A1 (en)	2003-12-02	Attenuation of metapneumovirus
AU2003210983A1 (en)	2003-09-04	Kinase inhibitors and methods of use thereof
AU2003279841A1 (en)	2004-05-04	Uses of human zven antagonists
AU2002238103A1 (en)	2002-08-28	Use of beta-lactamase inhibitors as neuroprotectants
HUP0401641A3 (en)	2007-02-28	Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2002367730A1 (en)	2003-09-09	Use of leukotriene receptor antagonist for treatment of scarring
AU2003288857A1 (en)	2004-07-09	New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor
AU2003297612A1 (en)	2004-06-23	2-substituted-3-propenamide derivatives and methods of using the same

Legal Events

Date	Code	Title	Description
2005-09-01	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase